Story perspectives
Trump's Drug Price Order: Benefit for Pfizer, Not Patients
10/7/2025
36 4
1 of 1
Story summary
- President Donald Trump issued an executive order to lower drug prices and announced Pfizer-discount partnership via TrumpRx.
- Senator Bernie Sanders calls high U.S. drug prices an outrage, matching Trump's stance.
- Analysts say the Pfizer deal mainly benefits Pfizer, not American patients.
- The arrangement preserves the status quo; Big Pharma has spent over $6.3 billion lobbying since 1998.
